Cytosorbents Crp Net Worth
Cytosorbents Crp Net Worth Breakdown | CTSO |
Cytosorbents Crp Net Worth Analysis
Cytosorbents Crp's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Cytosorbents Crp's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Cytosorbents Crp's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Cytosorbents Crp's net worth analysis. One common approach is to calculate Cytosorbents Crp's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Cytosorbents Crp's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Cytosorbents Crp's net worth. This approach calculates the present value of Cytosorbents Crp's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Cytosorbents Crp's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Cytosorbents Crp's net worth. This involves comparing Cytosorbents Crp's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Cytosorbents Crp's net worth relative to its peers.
Enterprise Value |
|
To determine if Cytosorbents Crp is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Cytosorbents Crp's net worth research are outlined below:
| Cytosorbents Crp had very high historical volatility over the last 90 days | |
| Cytosorbents Crp has some characteristics of a very speculative penny stock | |
| Cytosorbents Crp has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the previous year's revenue of 36.35 M. Net Loss for the year was (28.51 M) with profit before overhead, payroll, taxes, and interest of 23.67 M. | |
| Cytosorbents Crp currently holds about 30.16 M in cash with (21.66 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.69. | |
| Cytosorbents Crp has a frail financial position based on the latest SEC disclosures | |
| Latest headline from simplywall.st: Disposition of 32625 shares by Mariani Peter J of Cytosorbents Crp at 1.0 subject to Rule 16b-3 |
Cytosorbents Crp uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Cytosorbents Crp. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Cytosorbents Crp's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 14th of March 2024 Upcoming Quarterly Report | View | |
| 7th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 14th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Cytosorbents Crp's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Cytosorbents Crp is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cytosorbents Crp backward and forwards among themselves. Cytosorbents Crp's institutional investor refers to the entity that pools money to purchase Cytosorbents Crp's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Advisor Group Holdings, Inc. | 2024-09-30 | 122.4 K | Morgan Stanley - Brokerage Accounts | 2024-09-30 | 114 K | Amh Equity Ltd | 2024-09-30 | 82.8 K | Renaissance Technologies Corp | 2024-09-30 | 79.6 K | Northern Trust Corp | 2024-09-30 | 74.9 K | Raymond James Finl Svs Advisors, Inc. | 2024-09-30 | 60.6 K | Raymond James & Associates | 2024-09-30 | 50 K | Stifel Financial Corp | 2024-09-30 | 45 K | Key Client Fiduciary Advisors, Llc | 2024-12-31 | 34.6 K | Avenir Corporation | 2024-09-30 | 3 M | Skylands Capital, Llc | 2024-09-30 | 2.8 M |
Follow Cytosorbents Crp's market capitalization trends
The company currently falls under 'Micro-Cap' category with a current market capitalization of 60.32 M.Market Cap |
|
Project Cytosorbents Crp's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.52) | (0.55) | |
| Return On Capital Employed | (0.93) | (0.88) | |
| Return On Assets | (0.48) | (0.51) | |
| Return On Equity | (1.41) | (1.34) |
When accessing Cytosorbents Crp's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Cytosorbents Crp's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Cytosorbents Crp's profitability and make more informed investment decisions.
Evaluate Cytosorbents Crp's management efficiency
Cytosorbents Crp has return on total asset (ROA) of (0.2793) % which means that it has lost $0.2793 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.185) %, meaning that it created substantial loss on money invested by shareholders. Cytosorbents Crp's management efficiency ratios could be used to measure how well Cytosorbents Crp manages its routine affairs as well as how well it operates its assets and liabilities. As of the 1st of February 2025, Return On Tangible Assets is likely to drop to -0.55. In addition to that, Return On Capital Employed is likely to grow to -0.88. At this time, Cytosorbents Crp's Total Assets are very stable compared to the past year. As of the 1st of February 2025, Non Current Assets Total is likely to grow to about 33.3 M, while Total Current Assets are likely to drop about 17.6 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.60 | 0.58 | |
| Tangible Book Value Per Share | 0.50 | 0.51 | |
| Enterprise Value Over EBITDA | (1.66) | (1.74) | |
| Price Book Value Ratio | 1.92 | 2.01 | |
| Enterprise Value Multiple | (1.66) | (1.74) | |
| Price Fair Value | 1.92 | 2.01 | |
| Enterprise Value | 48.4 M | 93.7 M |
Leadership at Cytosorbents Crp emphasizes sustainable growth and financial prudence. Our analysis evaluates how these priorities impact the stock's performance in the market.
Enterprise Value Revenue 2.4281 | Revenue | Quarterly Revenue Growth 0.066 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Cytosorbents Crp insiders, such as employees or executives, is commonly permitted as long as it does not rely on Cytosorbents Crp's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Cytosorbents Crp insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Cytosorbents Crp time-series forecasting models is one of many Cytosorbents Crp's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cytosorbents Crp's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
Cytosorbents Crp Earnings per Share Projection vs Actual
Cytosorbents Crp Corporate Management
| CPA CPA | CFO Sec | Profile | |
| Robert MD | CoChairman Consultant | Profile | |
| MS MS | Pres COO | Profile | |
| Christian MD | Executive Marketing | Profile | |
| MS MBA | Senior Development | Profile | |
| Terri MBA | Vice Communications | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cytosorbents Crp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytosorbents Crp. If investors know Cytosorbents will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytosorbents Crp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.36) | Revenue Per Share | Quarterly Revenue Growth 0.066 | Return On Assets | Return On Equity |
The market value of Cytosorbents Crp is measured differently than its book value, which is the value of Cytosorbents that is recorded on the company's balance sheet. Investors also form their own opinion of Cytosorbents Crp's value that differs from its market value or its book value, called intrinsic value, which is Cytosorbents Crp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytosorbents Crp's market value can be influenced by many factors that don't directly affect Cytosorbents Crp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytosorbents Crp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytosorbents Crp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytosorbents Crp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.